Shenzhen RongDa Photosensitive Science & Technology Past Earnings Performance
Past criteria checks 2/6
Shenzhen RongDa Photosensitive Science & Technology has been growing earnings at an average annual rate of 21.5%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 12.9% per year. Shenzhen RongDa Photosensitive Science & Technology's return on equity is 8.4%, and it has net margins of 12.3%.
Key information
21.5%
Earnings growth rate
20.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 12.9% |
| Return on equity | 8.4% |
| Net Margin | 12.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Profits Appear To Have Quality Issues
Nov 06
Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Earnings Are Of Questionable Quality
Apr 15Recent updates
Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Profits Appear To Have Quality Issues
Nov 06Shenzhen RongDa Photosensitive Science & Technology Co., Ltd. (SZSE:300576) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Oct 08Returns On Capital At Shenzhen RongDa Photosensitive Science & Technology (SZSE:300576) Have Hit The Brakes
Oct 04Does Shenzhen RongDa Photosensitive Science & Technology (SZSE:300576) Deserve A Spot On Your Watchlist?
Aug 22Shenzhen RongDa Photosensitive Science & Technology Co., Ltd.'s (SZSE:300576) Shares Climb 28% But Its Business Is Yet to Catch Up
Jun 10Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Earnings Are Of Questionable Quality
Apr 15Slowing Rates Of Return At Shenzhen RongDa Photosensitive Science & Technology (SZSE:300576) Leave Little Room For Excitement
Apr 08What Shenzhen RongDa Photosensitive Science & Technology Co., Ltd.'s (SZSE:300576) 26% Share Price Gain Is Not Telling You
Feb 29Revenue & Expenses Breakdown
How Shenzhen RongDa Photosensitive Science & Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 908 | 111 | 143 | 53 |
| 30 Jun 24 | 876 | 113 | 135 | 49 |
| 31 Mar 24 | 839 | 104 | 128 | 45 |
| 31 Dec 23 | 799 | 85 | 125 | 43 |
| 30 Sep 23 | 772 | 99 | 121 | 38 |
| 30 Jun 23 | 737 | 77 | 122 | 36 |
| 31 Mar 23 | 729 | 60 | 119 | 36 |
| 01 Jan 23 | 735 | 53 | 118 | 36 |
| 30 Sep 22 | 757 | 31 | 118 | 42 |
| 30 Jun 22 | 788 | 36 | 118 | 42 |
| 31 Mar 22 | 785 | 33 | 122 | 42 |
| 01 Jan 22 | 786 | 40 | 128 | 41 |
| 30 Sep 21 | 737 | 58 | 115 | 35 |
| 30 Jun 21 | 672 | 59 | 106 | 32 |
| 31 Mar 21 | 622 | 66 | 90 | 28 |
| 31 Dec 20 | 544 | 57 | 76 | 25 |
| 30 Sep 20 | 507 | 53 | 77 | 24 |
| 30 Jun 20 | 481 | 42 | 75 | 23 |
| 31 Mar 20 | 446 | 36 | 75 | 23 |
| 31 Dec 19 | 455 | 38 | 75 | 23 |
| 30 Sep 19 | 438 | 37 | 72 | 23 |
| 30 Jun 19 | 435 | 41 | 64 | 22 |
| 31 Mar 19 | 434 | 43 | 62 | 22 |
| 31 Dec 18 | 423 | 42 | 59 | 21 |
| 30 Sep 18 | 414 | 37 | 56 | 21 |
| 30 Jun 18 | 394 | 37 | 47 | 29 |
| 31 Mar 18 | 381 | 36 | 51 | 24 |
| 31 Dec 17 | 363 | 37 | 54 | 19 |
| 30 Sep 17 | 346 | 38 | 58 | 15 |
| 30 Jun 17 | 336 | 36 | 70 | 0 |
| 31 Mar 17 | 324 | 36 | 69 | 0 |
| 31 Dec 16 | 314 | 34 | 68 | 0 |
| 30 Sep 16 | 301 | 40 | 60 | 0 |
| 31 Dec 15 | 277 | 33 | 54 | 0 |
| 31 Dec 14 | 275 | 24 | 58 | 0 |
| 31 Dec 13 | 243 | 24 | 49 | 0 |
Quality Earnings: 300576 has a high level of non-cash earnings.
Growing Profit Margin: 300576's current net profit margins (12.3%) are lower than last year (12.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300576's earnings have grown significantly by 21.5% per year over the past 5 years.
Accelerating Growth: 300576's earnings growth over the past year (13%) is below its 5-year average (21.5% per year).
Earnings vs Industry: 300576 earnings growth over the past year (13%) exceeded the Chemicals industry -5.3%.
Return on Equity
High ROE: 300576's Return on Equity (8.4%) is considered low.